Page last updated: 2024-08-22

samarium and organophosphonates

samarium has been researched along with organophosphonates in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's4 (66.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aas, M; Bruland, OS; Gamlem, H; Moe, L; Ottesen, N; Skretting, A1
Faivre-Chauvet, A; Gestin, JF; Loussouarn, A; Morandeau, L; Ouadi, A; Remaud, P; Webb, J1
Essman, SC; Fox, DB; Lewis, MR1
Försterová, M; Gano, L; Hermann, P; Jandurová, Z; Lubal, P; Marques, F; Santos, I; Vanek, J1
Abaya, CD; Berenson, JR; Duvivier, H; Mapes, R; Nassir, Y; Patel, R; Swift, RA; Yellin, O1
Chakraborty, S; Chakravarty, R; Dash, A; Khan, MS; Ram, R; Sarma, HD1

Trials

1 trial(s) available for samarium and organophosphonates

ArticleYear
A phase I study of samarium lexidronam/bortezomib combination therapy for the treatment of relapsed or refractory multiple myeloma.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2009, Feb-01, Volume: 15, Issue:3

    Topics: Antineoplastic Combined Chemotherapy Protocols; Boronic Acids; Bortezomib; Combined Modality Therapy; Drug Administration Schedule; Ethylenediamines; Humans; Maximum Tolerated Dose; Multiple Myeloma; Organophosphonates; Platelet Count; Pyrazines; Radioisotopes; Recurrence; Samarium

2009

Other Studies

5 other study(ies) available for samarium and organophosphonates

ArticleYear
Internal radionuclide therapy of primary osteosarcoma in dogs, using 153Sm-ethylene-diamino-tetramethylene-phosphonate (EDTMP).
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1999, Volume: 5, Issue:10 Suppl

    Topics: Animals; Bone Neoplasms; Brachytherapy; Dogs; Female; Male; Neoplasm Metastasis; Organophosphonates; Osteosarcoma; Radiotherapy Dosage; Samarium

1999
Influence of trans-1,2-diaminocyclohexane structure and mixed carboxylic/phosphonic group combinations on samarium-153 chelation capacity and stability.
    European journal of medicinal chemistry, 2004, Volume: 39, Issue:5

    Topics: Carboxylic Acids; Chelating Agents; Cyclohexylamines; Drug Stability; Humans; Isotope Labeling; Ligands; Organometallic Compounds; Organophosphonates; Organophosphorus Compounds; Radioisotopes; Samarium

2004
Effects of increasing doses of samarium-153-ethylenediaminetetramethylene phosphonate on axial and appendicular skeletal growth in juvenile rabbits.
    Nuclear medicine and biology, 2008, Volume: 35, Issue:2

    Topics: Animals; Bone and Bones; Bone Development; Dose-Response Relationship, Radiation; Female; Growth Plate; Organophosphonates; Rabbits; Radioisotopes; Radionuclide Imaging; Radiopharmaceuticals; Radiotherapy Dosage; Samarium

2008
Chemical and biological evaluation of 153Sm and 166Ho complexes of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetrakis(methylphosphonic acid monoethylester) (H4 dotp OEt).
    Journal of inorganic biochemistry, 2008, Volume: 102, Issue:7

    Topics: Animals; Bone and Bones; Drug Stability; Esters; Holmium; Humans; Ligands; Organophosphonates; Radioisotopes; Radiopharmaceuticals; Samarium; Tissue Distribution

2008
An electrochemical approach for removal of radionuclidic contaminants of Eu from
    Nuclear medicine and biology, 2018, Volume: 58

    Topics: Animals; Bone Neoplasms; Cancer Pain; Electrochemistry; Europium; Feasibility Studies; Organophosphonates; Palliative Care; Radiochemistry; Radioisotopes; Rats; Rats, Wistar; Samarium

2018